Medical Testing Equipment Businesses for Sale in Newmarket

Located in New Hampshire, the company is currently in an updated pre-revenue version. The original version established a strong foundation focused on preventing substance abuse among children and families. - The business was created to address one of the most critical and unmet public health needs: the high risk of drug use beginning in childhood. - The company offers a laboratory-based home drug testing system, developed specifically to empower parents with an effective, anonymous, and preventive solution to identify early drug exposure in children. - This product is the first and only of its kind to receive U. S. FDA premarket approval at the PMA Level III, the highest regulatory standard for medical devices. It is also approved by the UK Medical Device Agency (MDA). - Unlike traditional drug testing solutions, the system is designed for home use while maintaining laboratory-grade accuracy, making it a unique plug-and-play acquisition opportunity for clinical and medical laboratories. - The product demonstrated strong commercial viability 28 years ago, generating over USD 2.6 million in sales revenue. - Due to the founder’s health, the product remained commercially dormant for several years despite its proven market demand. - In recent years, drug-related dangers and fatalities particularly among youth and first-time users exposed to substances such as fentanyl have increased significantly. - In response, the product underwent substantial revisions and was restructured into an LLC to enhance commercial scalability and operational readiness. - The system now directly addresses unmet medical and public health needs affecting over 73 million children and their families, positioning it as a critical preventive tool in today’s substance abuse landscape. - The product’s consumer market is global, with projected revenues in the billions of dollars. Results remain anonymous, increasing consumer adoption and trust. - Clinical laboratories and retail outlets are ideally positioned independently or in collaboration to rapidly capture a significant share of the consumer diagnostics market without incurring substantial risk. - By offering this FDA- and UK MDA-approved testing system, partners gain immediate access to a new, high-margin revenue stream. - The product is fully developed and ready for immediate commercialization, providing acquirers or partners with a rare opportunity to enter a $2+ billion consumer diagnostics market with the only FDA-approved laboratory-based home drug testing system of its kind.

Located in New Hampshire, the company is currently in an updated pre-revenue version. The original version established a strong foundation focused on preventing substance abuse among children and families. - The business was created to address one of the most critical and unmet public health needs: the high risk of drug use beginning in childhood. - The company offers a laboratory-based home drug testing system, developed specifically to empower parents with an effective, anonymous, and preventive solution to identify early drug exposure in children. - This product is the first and only of its kind to receive U. S. FDA premarket approval at the PMA Level III, the highest regulatory standard for medical devices. It is also approved by the UK Medical Device Agency (MDA). - Unlike traditional drug testing solutions, the system is designed for home use while maintaining laboratory-grade accuracy, making it a unique plug-and-play acquisition opportunity for clinical and medical laboratories. - The product demonstrated strong commercial viability 28 years ago, generating over USD 2.6 million in sales revenue. - Due to the founder’s health, the product remained commercially dormant for several years despite its proven market demand. - In recent years, drug-related dangers and fatalities particularly among youth and first-time users exposed to substances such as fentanyl have increased significantly. - In response, the product underwent substantial revisions and was restructured into an LLC to enhance commercial scalability and operational readiness. - The system now directly addresses unmet medical and public health needs affecting over 73 million children and their families, positioning it as a critical preventive tool in today’s substance abuse landscape. - The product’s consumer market is global, with projected revenues in the billions of dollars. Results remain anonymous, increasing consumer adoption and trust. - Clinical laboratories and retail outlets are ideally positioned independently or in collaboration to rapidly capture a significant share of the consumer diagnostics market without incurring substantial risk. - By offering this FDA- and UK MDA-approved testing system, partners gain immediate access to a new, high-margin revenue stream. - The product is fully developed and ready for immediate commercialization, providing acquirers or partners with a rare opportunity to enter a $2+ billion consumer diagnostics market with the only FDA-approved laboratory-based home drug testing system of its kind.